Home › Funds › ACUTA CAPITAL PARTNERS, LLC › SLN
ACUTA CAPITAL PARTNERS, LLC position in SLN
SILENCE THERAPEUTICS PLC · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 393,583 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q3 2026 13F filing — a position valued at US$4.3M, representing 3.39% of its reported portfolio and ranking #10 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's SLN position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in SLN in Q3 2026 at 393,583 shares (US$4.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 393.58K | $4.30M | New |
About SLN and 13F data
SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 43 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$31.6M), Redmile Group, LLC (US$23.8M), TCG Crossover Management, LLC (US$19.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLN
- Siren, L.L.C. 2.89M sh · $31.56M · Q3 2026
- Redmile Group, LLC 2.16M sh · $23.77M · Q2 2026
- TCG Crossover Management, LLC 1.82M sh · $19.88M · Q3 2026
- Nextech Invest Ltd. 952.40K sh · $10.46M · Q2 2026
- KVP Capital Advisors, LP 684.12K sh · $7.48M · Q3 2026
- Tetragon Partners GP Ltd 500.00K sh · $5.46M · Q3 2026
- 5AM Venture Management, LLC 476.20K sh · $5.23M · Q2 2026
- GREAT POINT PARTNERS LLC 450.00K sh · $4.94M · Q2 2026
- Fortress Investment Group LLC 230.00K sh · $2.51M · Q3 2026
- Sofinnova Investments, Inc. 211.80K sh · $2.31M · Q3 2026
- Ishara Investments LP 160.00K sh · $1.75M · Q3 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held SLN?
ACUTA CAPITAL PARTNERS, LLC has disclosed SLN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACUTA CAPITAL PARTNERS, LLC's current position in SLN?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 393.58K shares of SLN (SILENCE THERAPEUTICS PLC), valued at $4.30M, representing 3.39% of its reported portfolio and ranking #10.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling SLN?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in SLN.
Which other funds hold SLN?
Other major institutional holders of SLN include Siren, L.L.C., Redmile Group, LLC, TCG Crossover Management, LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.